Administration of Nicotinamide Mononucleotide in the Treatment of Disease
Copyright © Targeted News Service 2024
2024-11-26
ALEXANDRIA, Virginia, Nov. 26 -- WASHINGTON UNIVERSITY, St. Louis, Missouri has been assigned a patent (No. US 12150950 B2, initially filed Sept. 21, 2023) developed by Shin-Ichiro Imai, St. Louis, Missouri, and Rajendra Apte, Clayton, Missouri, for "Administration of nicotinamide mononucleotide in the treatment of disease." . . .